官方微信|手機版|本站服務(wù)|買家中心|行業(yè)動態(tài)|幫助

產(chǎn)品|公司|采購|招標(biāo)

血管內(nèi)皮生長因子抗體anti-VEGF

參考價面議
具體成交價以合同協(xié)議為準(zhǔn)
  • 公司名稱齊一生物科技(上海)有限公司
  • 品       牌
  • 型       號
  • 所  在  地上海市
  • 廠商性質(zhì)生產(chǎn)廠家
  • 更新時間2015/7/29 16:20:42
  • 訪問次數(shù)2075
在線詢價 收藏產(chǎn)品 進入商鋪 同類產(chǎn)品

聯(lián)系方式:程成 查看聯(lián)系方式

該公司近期關(guān)注度409703

聯(lián)系我們時請說明是 制藥網(wǎng) 上看到的信息,謝謝!

齊一生物主要覆蓋于免疫學(xué),分子生物學(xué),病理學(xué),生物化學(xué)細(xì)胞生物學(xué)生命科學(xué)的各個領(lǐng)域。已迅速發(fā)展成為國內(nèi)科學(xué)試劑的運營商之一,是國家重點實驗室*供應(yīng)商,并與國內(nèi)多家科研單位緊密合作。

齊一生物致力于檢測試劑盒的自主研發(fā)、生產(chǎn)和銷售以及樣本檢測等技術(shù)服務(wù)經(jīng)營為一體的專業(yè)化生物工程技術(shù)公司!為廣大科研工作者、企業(yè)和校提供質(zhì)優(yōu)價廉的實驗室用品


齊一生物長期經(jīng)營ELISA試劑盒,進口ELISA試劑盒及抗體(免費代測),分子學(xué)生物試劑盒,金標(biāo)法檢測試劑盒,比色法檢測試劑盒,細(xì)胞菌株,培養(yǎng)基,細(xì)胞因子,生化試劑,耗材等生物試劑產(chǎn)品
血管內(nèi)皮生長因子抗體anti-VEGF齊一生物科技(上海)有限公司新品*歡迎您訪問我們的如有什么問題請給我們或者留言741653262,告訴我您的需要,并留下您寶貴的意見和建議.
血管內(nèi)皮生長因子抗體anti-VEGF 產(chǎn)品信息

血管內(nèi)皮生長因子抗體anti-VEGF齊一生物科技(上海)有限公司新品*歡迎您訪問我們的如有什么問題請給我們或者留言741653262,告訴我您的需要,并留下您寶貴的意見和建議.

血管內(nèi)皮生長因子抗體anti-VEGF英文名稱VEGF
中文名稱血管內(nèi)皮生長因子抗體
別    名Vascuoar endothelial growth factor A; VEGF A; vascular endothelial growth factor A isoform 2 precursor; Vegf; VEGFA; MGC70609; MVCD1; VEGF; VPF; VEGFA_HUMAN; Vascular endothelial growth factor A; VEGF-A; Vascular permeability factor; VPF; VEGF A Precursor.
研究領(lǐng)域腫瘤  細(xì)胞生物  免疫學(xué)  信號轉(zhuǎn)導(dǎo)  生長因子和激素  血管內(nèi)皮細(xì)胞  
抗體來源Rabbit
克隆類型Polyclonal
交叉反應(yīng)Dog, Pig, Cow, Horse, Rabbit, Sheep, ,.
產(chǎn)品應(yīng)用WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 (石蠟切片需做抗原修復(fù)) 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量24kDa
細(xì)胞定位細(xì)胞外基質(zhì) 分泌型蛋白 
性    狀Lyophilized or Liquid
濃    度1mg/1ml
免 疫 原KLH conjugated synthetic peptide derived from human VEGF
亞    型IgG
純化方法affinity purified by Protein A
儲 存 液Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
保存條件Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
產(chǎn)品介紹background:
This gene product is a member of the PDGF/VEGF growth factor family. It is a mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis, endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. Also, alternative translation initiation from non-AUG (CUG) and AUG start sites in some transcript variants, give rise to additional isoforms. [provided by RefSeq]. 

Function:
Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. Binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. NRP1/Neuropilin-1 binds isoforms VEGF-165 and VEGF-145. Isoform VEGF165B binds to KDR but does not activate downstream signaling pathways, does not activate angiogenesis and inhibits tumor growth.

Subunit:
Homodimer; disulfide-linked. Also found as heterodimer with PGF

Subcellular Location:
Secreted. Note=VEGF121 is acidic and freely secreted. VEGF165 is more basic, has heparin-binding properties and, although a signicant proportion remains cell-associated, most is freely secreted. VEGF189 is very basic, it is cell-associated after secretion and is bound avidly by heparin and the extracellular matrix, although it may be released as a soluble form by heparin, heparinase or plasmin.

Tissue Specificity:
Isoform VEGF189, isoform VEGF165 and isoform VEGF121 are widely expressed. Isoform VEGF206 and isoform VEGF145 are not widely expressed.

DISEASE:
Defects in VEGFA are a cause of susceptibility to microvascular plications of diabetes type 1 (MVCD1) [MIM:603933]. These are pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus. They include diabetic retinopathy, diabetic nephropathy leading to end-stage renal disease, and diabetic neuropathy. Diabetic retinopathy remains the major cause of new-onset blindness among diabetic adults. It is characterized by vascular permeability and increased tissue ischemia and angiogenesis.

Similarity:
Belongs to the PDGF/VEGF growth factor family.

Database links:
UniProtKB/Swiss-Prot: P15692.2

Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

血管內(nèi)皮細(xì)胞生長因子(VEGF)是一種特異作用于血管內(nèi)皮細(xì)胞的多功能細(xì)胞因子,它能引起血管通透性增加,引起細(xì)胞外基質(zhì)成分改變,誘導(dǎo)血管形成。在炎癥、創(chuàng)傷愈合、心臟缺血、動脈粥樣硬化、糖尿病性視網(wǎng)膜病變及腫瘤形成等與血管生成和病變有關(guān)的諸多病理過程中起重要作用。VEGF與血管生成有關(guān),從而也與腫瘤生長也有很大關(guān)系,近年來受到廣泛關(guān)。


同類產(chǎn)品推薦
在找 血管內(nèi)皮生長因子抗體anti-VEGF 產(chǎn)品的人還在看

提示

×

*您想獲取產(chǎn)品的資料:

以上可多選,勾選其他,可自行輸入要求

個人信息: